<DOC>
	<DOCNO>NCT00790257</DOCNO>
	<brief_summary>In view avoid immunosuppression , investigator submit Phase 1 clinical trial protocol test safety efficacy encapsulate human islet `` Monolayer Cellular Device '' allogeneic islet transplantation Type 1 diabetic patient perform University clinical hospital Saint-Luc , Brussels . Encapsulated human islet transplant subcutaneous tissue `` safety procedure '' patient . This protocol ( single center trial ) design limited series islet transplant 15 Type 1 diabetic adult subject .</brief_summary>
	<brief_title>Safety Efficacy Study Encapsulated Human Islets Allotransplantation Treat Type 1 Diabetes</brief_title>
	<detailed_description>The need chronic immunosuppressive therapy parallel occurrence undesirable side effect islets transplantation well whole pancreas transplantation . Several complication associate administration standard immunosuppressive agent ( base use Sirolimus Tacrolimus example ) use human islet allotransplantation . The herein present protocol Phase 1 pilot study . This single center clinical study . Study divide 2 Phases . - Phase 1A : T1DM patient , already transplant organ ( kidney , heart , liver totally unfunctioning primary whole vascularize pancreas ) immunosuppression , receive `` Monolayer Cellular Device '' subcutaneous tissue view ass capacity encapsulate human islet secrete insulin without immunological reaction . - Phase 1B : T1DM patient receive `` Monolayer Cellular Device '' subcutaneous tissue without immunosuppression view assess biocompatibility device . This protocol design limited series islet transplant 15 Type 1 diabetic adult subject . In Pase 1A/1B : Vascularized pancreas transplantation propose , patient , follow vascular disease , old age , psychological reason . Phase 1A consists transplantation encapsulate human islet Type 1 diabetic patient already transplant primary vascularized organ immunosuppression therapy . Phase 1B consists transplantation encapsulate human islet Type 1 diabetic patient eligible whole vascularize pancreas transplantation .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Phase 1A : 1 . Male female patient , 30 80 year age , Cpeptidenegative ; 2 . Patient must sign Patient Informed Consent Form ; 3 . Type 1 diabetic ( T1DM ) patient insulindependent ; 4 . T1DM patient already transplant kidney graft already immunosuppressive therapy ; 5 . T1DM patient already transplant vascularized pancreas , already immunosuppressive therapy , TOTAL dysfunction graft ; 6 . T1DM patient already transplant liver graft already immunosuppressive therapy ; 7 . T1DM patient already transplant heart lung graft already immunosuppressive therapy ; 8 . T1DM patient eligible simultaneous transplantation kidney encapsulate human islet ; 9 . DonorRecipient ABO blood group compatibility ; 10 . Donor Recipient HLA compatibility . Phase 1B : 1 . Male female patient , 30 80 year age , Cpeptidenegative ; 2 . Patient must sign Patient Informed Consent Form ; 3 . T1DM patient without immunosuppression transplant vascularized pancreas ( vascular complication , psychological reason , ... ) . The main objective restore residual insulin secretion stabilize diabetes ( reduction hypoglycaemia , â€¦ ) ; 4 . DonorRecipient ABO blood group compatibility ; 5 . Donor Recipient HLA compatibility . RECIPIENT EXCLUSION CRITERIA FOR PHASE 1A/B : 1 . Patient pregnant breastfeeding . 2 . Patient positive Tcell crossmatch recent serum specimen . 3 . Patient malignancy history malignancy , exception adequately treat localised squamous cell basal cell carcinoma , without recurrence . 4 . Patient include another clinical trial protocol investigational drug within 4 week prior inclusion UCLHIA002 . 5 . Patient form substance abuse , psychiatric disorder condition , , opinion investigator , may invalidate communication .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Islets transplantation</keyword>
	<keyword>Encapsulation</keyword>
</DOC>